Document is current
Any future updates will be listed below
-
Authors
McConnell, Kelly M. https://orcid.org/0000-0002-2018-1860
Zaleta, Alexandra K.
Saracino, Rebecca
Miller, Melissa
-
Funding
Funding for this research was provided by:
National Cancer Insitute (R21CA270208)
National Cancer Institute (4P30CA008748-58)
- License Information
-
More Information
Article History
Accepted: 8 August 2024
First Online: 20 August 2024
Declarations
:
: Zaleta reports institutional research funding from AstraZeneca, Bristol Myers Squibb, Exelixis, GSK, Lilly, Merck, Pfizer, Regeneron. Miller reports institutional research funding from Astellas Pharma, BeiGene, Bristol Myers Squibb, Genentech, Geron, Gilead Sciences, GSK, Janssen Oncology, Merck, Novartis, Novocure, Pfizer, Seagen, Taiho Oncology, and Takeda Oncology.
: Ethical and Independent Review Services (E&I, Independence, MO) served as the IRB of record (Study #16,036). All procedures were in accordance with the ethical standards of the institutional research committee for studies involving human participants and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards.
: Informed consent was obtained from all participants.
